- About this Journal ·
- Abstracting and Indexing ·
- Advance Access ·
- Aims and Scope ·
- Annual Issues ·
- Article Processing Charges ·
- Articles in Press ·
- Author Guidelines ·
- Bibliographic Information ·
- Citations to this Journal ·
- Contact Information ·
- Editorial Board ·
- Editorial Workflow ·
- Free eTOC Alerts ·
- Publication Ethics ·
- Reviewers Acknowledgment ·
- Submit a Manuscript ·
- Subscription Information ·
- Table of Contents
BioMed Research International
Volume 2014 (2014), Article ID 379847, 8 pages
Macrophage Capping Protein CapG Is a Putative Oncogene Involved in Migration and Invasiveness in Ovarian Carcinoma
1Department of Nephrology, University Hospital Duesseldorf, Heinrich-Heine University, 40225 Duesseldorf, Germany
2Department of Obstetrics and Gynecology, University Hospital Duesseldorf, Heinrich-Heine University, 40225 Duesseldorf, Germany
3Department of Oncology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China
4Institute of Human Genetics, University Hospital Duesseldorf, Heinrich-Heine University, 40225 Duesseldorf, Germany
Received 17 December 2013; Accepted 11 February 2014; Published 2 April 2014
Academic Editor: Peter A. Fasching
Copyright © 2014 J. Glaser et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
- I. Persson, “Estrogens in the causation of breast, endometrial and ovarian cancers—evidence and hypotheses from epidemiological findings,” Journal of Steroid Biochemistry and Molecular Biology, vol. 74, no. 5, pp. 357–364, 2000.
- I.-M. Shih and R. J. Kurman, “Ovarian tumorigenesis: a proposed model based on morphological and molecular genetic analysis,” American Journal of Pathology, vol. 164, no. 5, pp. 1511–1518, 2004.
- A. Waldmann and N. E. A. Katalinic, “Epidemiology of malignant cervical, corpus uteri and ovarian tumours- current data and epidemiological trends,” Geburtshilfe und Frauenheilkunde, vol. 73, no. 2, pp. 123–129, 2013.
- R. J. Kurman and I.-M. Shih, “The origin and pathogenesis of epithelial ovarian cancer: a proposed unifying theory,” American Journal of Surgical Pathology, vol. 34, no. 3, pp. 433–443, 2010.
- J. A. McCubrey, L. S. Steelman, W. H. Chappell et al., “Roles of the Raf/MEK/ERK pathway in cell growth, malignant transformation and drug resistance,” Biochimica et Biophysica Acta, vol. 1773, no. 8, pp. 1263–1284, 2007.
- E. Lengyel, “Ovarian cancer development and metastasis,” American Journal of Pathology, vol. 177, no. 3, pp. 1053–1064, 2010.
- G. Singer, R. Stöhr, L. Cope et al., “Patterns of p53 mutations separate ovarian serous borderline tumors and low- and high-grade carcinomas and provide support for a new model of ovarian carcinogenesis: a mutational analysis with immunohistochemical correlation,” American Journal of Surgical Pathology, vol. 29, no. 2, pp. 218–224, 2005.
- A. van den Abbeele, V. de Corte, K. van Impe et al., “Downregulation of gelsolin family proteins counteracts cancer cell invasion in vitro,” Cancer Letters, vol. 255, no. 1, pp. 57–70, 2007.
- M. Renz, B. Betz, D. Niederacher, H. G. Bender, and J. Langowski, “Invasive breast cancer cells exhibit increased mobility of the actin-binding protein CapG,” International Journal of Cancer, vol. 122, no. 7, pp. 1476–1482, 2008.
- H. Nomura, K. Uzawa, T. Ishigami et al., “Clinical significance of gelsolin-like actin-capping protein expression in oral carcinogenesis: an immunohistochemical study of premalignant and malignant lesions of the oral cavity,” BMC Cancer, vol. 8, article 39, 2008.
- P. R. van Ginkel, R. L. Gee, T. M. Walker, D.-N. Hu, C. W. Heizmann, and A. S. Polans, “The identification and differential expression of calcium-binding proteins associated with ocular melanoma,” Biochimica et Biophysica Acta, vol. 1448, no. 2, pp. 290–298, 1998.
- C. C. Thompson, F. J. Ashcroft, S. Patel et al., “Pancreatic cancer cells overexpress gelsolin family-capping proteins, which contribute to their cell motility,” Gut, vol. 56, no. 1, pp. 95–106, 2007.
- E. Dahl, A. Sadr-Nabavi, E. Klopocki, et al., “Systematic identification and molecular characterization of genes differentially expressed in breast and ovarian cancer,” The Journal of Pathology, vol. 205, no. 1, pp. 21–28, 2005.
- K. Onoda, F.-X. Yu, and H. L. Yin, “gCap39 is a nuclear and cytoplasmic protein,” Cell Motility and the Cytoskeleton, vol. 26, no. 3, pp. 227–238, 1993.
- K. van Impe, V. de Corte, L. Eichinger et al., “The nucleo-cytoplasmic actin-binding protein CapG lacks a nuclear export sequence present in structurally related proteins,” Journal of Biological Chemistry, vol. 278, no. 20, pp. 17945–17952, 2003.
- V. de Corte, K. van Impe, E. Bruyneel et al., “Increased importin-β-dependent nuclear import of the actin modulating protein CapG promotes cell invasion,” Journal of Cell Science, vol. 117, no. 22, pp. 5283–5292, 2004.
- W. Witke, W. Li, D. J. Kwiatkowski, and F. S. Southwick, “Comparisons of CapG and gelsolin-null macrophages: demonstration of a unique role for CapG in receptor-mediated ruffling, phagocytosis, and vesicle rocketing,” Journal of Cell Biology, vol. 154, no. 4, pp. 775–784, 2001.
- U. K. Laemmli, “Cleavage of structural proteins during the assembly of the head of bacteriophage T4,” Nature, vol. 227, no. 5259, pp. 680–685, 1970.
- J.-H. Wu, X.-Y. Tian, and C.-Y. Hao, “The significance of a group of molecular markers and clinicopathological factors in identifying colorectal liver metastasis,” Hepato-Gastroenterology, vol. 58, no. 109, pp. 1182–1188, 2011.
- K. Partheen, K. Levan, L. Österberg et al., “Four potential biomarkers as prognostic factors in stage III serous ovarian adenocarcinomas,” International Journal of Cancer, vol. 123, no. 9, pp. 2130–2137, 2008.
- S. Kang, M. J. Kim, H. An et al., “Proteomic molecular portrait of interface zone in breast cancer,” Journal of Proteome Research, vol. 9, no. 11, pp. 5638–5645, 2010.
- C. Gest, P. Mirshahi, H. Li et al., “Ovarian cancer: stat3, RhoA and IGF-IR as therapeutic targets,” Cancer Letters, vol. 317, no. 2, pp. 207–217, 2012.
- P. Friedl and S. Alexander, “Cancer invasion and the microenvironment: plasticity and reciprocity,” Cell, vol. 147, no. 5, pp. 992–1009, 2011.
- M. Renz and J. Langowski, “Dynamics of the CapG actin-binding protein in the cell nucleus studied by FRAP and FCS,” Chromosome Research, vol. 16, no. 3, pp. 427–437, 2008.
- T. Hubert, K. Van Impe, J. Vandekerckhove, and J. Gettemans, “The F-actin filament capping protein CapG is a bona fide nucleolar protein,” Biochemical and Biophysical Research Communications, vol. 377, no. 2, pp. 699–704, 2008.
- I. A. Olave, S. L. Reck-Peterson, and G. R. Crabtree, “Nuclear actin and actin-related proteins in chromatin remodeling,” Annual Review of Biochemistry, vol. 71, pp. 755–781, 2002.
- J. Gettemans, K. Van Impe, V. Delanote, T. Hubert, J. Vandekerckhove, and V. De Corte, “Nuclear actin-binding proteins as modulators of gene transcription,” Traffic, vol. 6, no. 10, pp. 847–857, 2005.
- K. Onoda and H. L. Yin, “gCap39 is phosphorylated. Stimulation by okadaic acid and preferential association with nuclei,” Journal of Biological Chemistry, vol. 268, no. 6, pp. 4106–4112, 1993.
- E. Burillo, D. Recalde, E. Jarauta et al., “Proteomic study of macrophages exposed to oxLDL identifies a CAPG polymorphism associated with carotid atherosclerosis,” Atherosclerosis, vol. 207, no. 1, pp. 32–37, 2009.
- J. Kim, D. M. Coffey, C. J. Creighton, Z. Yu, S. M. Hawkins, and M. M. Matzuk, “High-grade serous ovarian cancer arises from fallopian tube in a mouse model,” Proceedings of the National Academy of Sciences of the United States of America, vol. 109, no. 10, pp. 3921–3926, 2012.
- C. G. Przybycin, R. J. Kurman, B. M. Ronnett, I.-M. Shih, and R. Vang, “Are all pelvic (Nonuterine) serous carcinomas of tubal origin?” American Journal of Surgical Pathology, vol. 34, no. 10, pp. 1407–1416, 2010.